Table 3 Correlations between sCD163, sTWEAK and sCD163/sTWEAK ratio and clinical and laboratory parameters of patients with systemic sclerosis.
Parameter (number of subjects) | RSpearman (P-value) | ||
|---|---|---|---|
sCD163 | sTWEAK | sCD163/sTWEAK | |
Disease duration (89) | -0.09 (P >0.05) | -0.32 P = 0.002 | 0.23 P = 0.03 |
Duration of Raynaud's phenomenon (54) | 0.14 (P >0.05) | 0.11 (P >0.05) | 0.03 (P >0.05) |
mRSS (82) | 0.03 (P >0.05) | -0.08 (P >0.05) | 0.13 (P >0.05) |
FVC (75) | -0.06 (P >0.05) | -0.22 (P >0.05) | 0.09 (P >0.05) |
DLCO (53) | -0.09 (P >0.05) | -0.05 (P >0.05) | -0.02 (P >0.05) |
PASP (57) | -0.14 (P >0.05) | -0.20 (P >0.05) | 0.11 (P >0.05) |
ESR (51) | 0.15 (P >0.05) | 0.07 (P >0.05) | 0.04 (P >0.05) |